Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: J Surg Res. 2018 Jul 14;232:283–292. doi: 10.1016/j.jss.2018.06.040

Figure 5:

Figure 5:

CYD0618 inhibits alternative pathway for NF-κB activation Western blots for LX-2 whole cell lysate after treatment with LPS alone, CYD0618 alone, or both for (A)LPS-stimulated and (B)endogenous NF-κB p65 and phosphorylated NF-κB p65. Densitometric analyses of bands were quantified and data expressed as fold of control normalized to GAPDH. P-values shown compared to vehicle.